(PRWEB) April 22, 2011
‘New Peyronie’s Research’, a TPRGlobal research news media service which gives men access to the latest Peyronie’s disease news and clinical trial information, has published three new extensive research articles on penile implants, the risks of ignoring Peyronie’s disease and the importance of an accurate and timely diagnosis of the disease.
The website, which currently lists Peyronie’s clinical trials in New Zealand, investigates the latest Peyronie’s disease research and discusses current, and future treatment options for men suffering from the condition.
‘New Peyronie’s Research’ frequently stresses the importance of informed dialogue and early diagnosis. It offers a “Clinical Trial: Fast Locator” for men interested in participating in treatment discovery.
The latest research articles on the website summarise a recent WebVNR interview with Dr. Stephen Mark – a Urological Surgeon based in Christchurch, New Zealand. Dr. Mark discusses current management options, risk factors, and the difficulties of finding quality information on the condition. One of Dr. Mark’s main messages is “Don’t ignore the problem”.
Another article discusses six primary reasons for an accurate and timely diagnosis of Peyronie’s Disease. Reason number two in the article reiterates Dr. Mark’s message of seeking early treatment because “the sooner Peyronie’s disease is diagnosed, the better”.
The most recent articles on ‘New Peyronie’s Research’ are based on research and information sourced from UroToday, Dr. Stephen Mark & WebVNR ,MedIndia, Mayo Clinic and Journal of Sexual Medicine.
Men interested in finding out more about current Peyronie’s disease clinical trials in New Zealand should visit the ‘New Peyronie’s Research’ Clinical Trials Directory.
Current clinical trial listings in New Zealand include trials at Primorus Clinical Trials Ltd (Christchurch), CURT Medical Trials Trust Board Inc (Christchurch), Wellington Urology Associates (Newtown, Wellington South), Waitemata Urology Research (Takapuna, Auckland), Tauranga Urology Research Ltd (Tauranga) and Cardinal Points Research Ltd (Whau Valley, Whangarei).
About TPRGlobal http://www.TPRglobal.com
TPRGlobal is a health news platform that uses geo-targeting and specialised content to connect qualified patients to the right clinical trials. The TPRGlobal heath news platforms deliver therapeutic area content to educate and inform people searching for health solutions. Our mission is to close the patient recruitment gap for patients and clinical studies.
Account Executive - DMG PR
+ 61 2 8006 0424
# # #